Developmental activation of VDJ recombination at the T cell receptor (TCR) 8 locus is controlled by an intronic transcriptional enhancer (Es). Transcriptional activation by E~ is dependent on c-Myb. To determine whether c-Myb plays a role in the activation of TCR-8 gene rearrangement, we compared VDJ recombination in transgenic mice carrying two versions of a human TCR-8 gene minilocus recombination substrate. One includes a wild-type Es, whereas the other carries an E 8 with a mutation that abrogates c-Myb binding. We demonstrate that an intact Myb binding site is necessary for efficient rearrangement of the minilocus substrate, suggesting that c-Myb plays a crucial role in activating VDJ recombination at the endogenous TCR-8 locus.
T
he protein c-Myb plays important roles in the differentiation and proliferation of hematopoietic cells (1, 2) . Gene-targeted c-myb-homozygous mutant mice die in utero and display severe anemia and other defects in hematopoiesis by fetal day 14.5 (3) . Further, T cell-specific overexpression of dominant-negative myb alleles in transgenic mice results in impaired T cell proliferation and differentiation (4) . However, because inhibition of Myb function has pleiotropic effects, specific roles for Myb proteins in vivo have remained elusive. Myb proteins activate transcription by specific binding to the nucleotide sequence PyAACT/GG (1, 2 ). Yet only a few genes that are specifically expressed in hematopoietic cells are known to be Myb targets (5) (6) (7) (8) (9) (10) . We have previously shown in transient transfection experiments that TCR-8 gene transcription is regulated by the T lineage-specific TCR-8 enhancer (Es) 1 (11) , and that the binding of c-Myb to the 8E3 element of E 8 is essential for enhancer activity (7) .
The regulated activation of VDJ recombination at TCR and Ig gene loci is an essential feature of lymphoid cell development (12, 13) . VDJ recombination has been correlated with germline transcription, suggesting a link between the two processes (14) (15) (16) (17) (18) . Direct evidence that transcriptional promoters and enhancers can regulate VDJ recombination in developing lymphocytes has been obtained from studies of transgenic mice that carry recombination substrates (19) (20) (21) (22) (23) (24) and from studies that use homoltAbbreviations used in this paper: CAT, chloramphenicol acetyl transferase; Es, TCR-8 enhancer; EsmMyb, E8 with a TCR-8 enhancer with a Myb-binding site mutation; 1.4E~BS, 1.4-kb wild-type E 8 subcloned into the XbaI site ofpBluescript KS+; E-, enhancerless. ogous recombination to eliminate regulatory elements from endogenous loci (25) (26) (27) .
We have previously studied VDJ recombination in transgenic mice carrying an unrearranged human TCR-B gene minilocus (22, 23) . This construct includes germline V~I, V82, DB3, Jal, J83, and Ca segments, as well as the TCR-8 enhancer (Es) within the J83-C8 intron. Frameshift mutations in the V segments prevent the expression of functional TCR chains such that the transgene serves as a neutral reporter of VDJ recombination. We found that transgene rearrangement is T cell specific and occurs stepwise, first V to D and then VD to J. Notably, in most lines of transgenic mice carrying a minilocus with E8 deleted, the initial V to D step still occurs, but the subsequent VD-to-J step is dramatically inhibited. This result suggests that E 8 is required for J segment accessibility, but is not required for V or D segment accessibility. This system therefore offers the opportunity to test the role of.specific cis-acting enhancer sequences in regulating VDJ recombination. In this study, we specifically address the role of Myb proteins in the recombinational enhancer activity of Es.
Materials and Methods
Production of Transgenic Mice. E8 with a Myb-binding site mutation (E~mMyb) was generated by PCR. using as a template the 1.4-kb wild-type Ea subcloned into the XbaI site of pBluescript KS+ (1.4EBBS). Mutagenic oligonucleotides MybPCRup and MybPCRdn that include a 2-bp change in the BE3 element and generate a HindllI site were described (7). Linearized plasmid was subjected to PCR in two different reactions including either oligonucleotides MybPCRup and EsPCR (AAGGTTTAATTC-AGTCAGAC) or MybPCR.dn and the reverse primer. The 5' 550-bp fragment was digested with HindlII and PflMI, the 3' 290-bp fragment was digested with HindlII and BamHI, and the two were ligated together into PflMI-and BamHI-digested 1.4EBBS. The insert was sequenced to confirm its structure, after which the 1.4-kb EsmMyb was excised with Xba[ and cloned into XbaI-digested, phosphatase-treated pBluescript carrying the enhancerless minilocus (22) . Minilocus DNA was purified and microinjected into fertilized C57BL/6 • SJL F2 eggs as described previously (22) . Transgenes were maintained on a mixed C57BL/6 • SJL background.
PCR. The preparation of genomic DNA, conditions for PCR., probes for Southern blot analysis, and quantification of PCR signals were as described (22) . The amount of template DNA used for PCR. reactions was 12 ng for single-copy integrants. Template quantity was reduced for multicopy integrants to account for copy number and to keep all PCR. signals in the linear range. Reported VD and VDJ rearrangement signals were normalized to the C~ signal for each DNA sample.
Transfection and Chloramphenicol Acetyl Transferase (CA T) Assays.
Enhancers were cloned upstream of the V81 promoter in XbaIdigested and phosphatase-treated Val-CAT (11) . The human T cell line Jurkat was transfected, and CAT assays were performed as described (7, 11) .
Results
A 2-bp mutation within the 8E3 element o f a 370-bp E~ fragment eliminates in vitro binding of c-Myb and abrogates transcriptional activation (7). The same 2-bp mutation was introduced into the 1.4-kb E~ fragment previously shown to regulate transgene rearrangement to generate E8mMyb ( Fig. 1 A) . W e first examined the effect o f the Myb binding site mutation on E8 transcriptional activity by subcloning E8 and EsmMyb into the enhancer-dependent test construct V~I-CAT, and assaying C A T activity after transient transfection of the constructs into Jurkat ceils (Fig.  2) . E8 was active in both orientations (38.7-and 34.8-fold induction), whereas EamMyb was completely inactive (0.5-and 0.2-fold induction). Thus, an intact Myb binding site within 8E3 is essential for the transcriptional activity of the 1.4-kb E8 as assayed by transient transfection.
E~mMyb was then substituted for the wild-type E~ within the transgenic minilocus ( Fig. 1 A) , and three independent lines of transgenic mice carrying the mutant enhancer were established. Minilocus rearrangements in three transgenic lines carrying wild-type E a (A, B, and C) (22) were compared with those in the three transgenic lines cartying EsmMyb (P, Q, and 1K). Ea lines A, B, and C each carry a single copy of the minilocus (22) . A m o n g the EamMyb lines, P carries three copies, Q carries four copies, and IK carries 15 copies. To assess transgene rearrangement, thymocyte genomic D N A templates were analyzed by quantitative PCR, and specific P C R products were identified by hybridization with radiolabeled V81 and Va2 c D N A probes (Fig. 1 B) . The primer combinations V~l-J~l and V82-Ja1 can amplify a product o f 0.3 kb that reflects VDJ rearrangement and one of 1.2 kb that reflects VD rearrangement (22) . The primer combinations Val-J83 and V81 rearrangement products generated using V81, J8l, and J~3 primers are depicted. Arrows denote PC1K primers. A similar set of V82 rearrangement products are generated using V82, J8l, and J83 primers. No products are amplified from unrearranged templates.
V~2-J~3 amplify only a 0,3-kb product that reflects VDJ rearrangement ( Fig. 1 B) . Amplification was also performed using a pair of C8 primers as an internal control. O f note, E8 line C carries a truncated minilocus that lacks the V81 gene segment, limiting the analysis to Va2 rearrangements in this line (22) . Consistent with previous experiments (22) , VDJ rearranged products were readily detectable with all four primer combinations in E8 lines A and B, and with V82 and J~ primers in E~ line C (Fig. 3 A) . Furthermore, as assessed using the primer combinations V8l-Jal and v~2-j81, VDJ- The indicated enhancers were tested in both orientations (arrows) upstream of the V81 promoter in the enhancer-dependent test construct V81-CAT. Jurkat cells were transfected in duplicate, and values for percent chloramphenicol acetylation were averaged and then normalized to the activity of the E-V81-CAT construct. rearranged products were more abundant than VD-rearranged products in each case, indicating that the enhancerdependent VD-to-J step of transgene rearrangement is highly efficient. Remarkably, the EamMyb lines displayed a very different phenotype. In all three lines and with every primer combination, the absolute amount of VDJ rearrangement was dramatically inhibited. Relative to E 8 line A, the levels of V81-D83-J81 rearrangement in the E~mMyb lines were 0.1% in P (i.e., [0.036/25.618] • 100), 0.2% in Q, and 5.4% in R, and the levels of V81-DB3-J~3 rearrangement were 0.1% in line P, 0.1% in Q, and 1.5% in R (Table 1) . Levels o f V82 rearrangements were similarly diminished. Furthermore, in all three lines, VD-rearranged products were more abundant than VDJ-rearranged products, indicating that the VD-to-J step of transgene rearrangement was preferentially inhibited. Some inhibition of the V -t o -D step of rearrangement was nevertheless apparent, most notably in line P. Similar conclusions were drawn from analysis o f a second individual in each of the EsmMybtransgenic lines (Fig. 3 B) . W e also analyzed minilocus rearrangement directly by genomic Southern blot (Fig. 4) . Unlike the P C R experiments, in which D N A samples were adjusted to normalize for copy number before analysis, in this experiment similar quantities o f g e n o m i c D N A were analyzed. In accord with the P C R data, thymus D N A from E8 line A displayed a low level o f V81-D83 rearrangement (0.9 kb), and higher levels of Val-Da3-J81 and V81-D83-J83 rearrangement (1.7 and 3.2 kb, respectively). This rearrangement profile was dramatically perturbed in EsmMyb lines P, Q, and R. R earrangement was undetectable in line P. Line Q displayed a high level of VD rearrangement but no VDJ rearrangement, whereas line R displayed a high level of VD rearrangement and a very low level o f VDJ rearrangement. Notably, VDJ rearrangement in line R was just barely detected by genomic Southern blot despite a 15-fold increase in transgene copy number relative to E8 line A. The South- Figure 4 . Minilocus Vs1 rearrangement analyzed by genomic Southern blot. PstI plus EcoRI-digested tail (germline control) and thymus DNA samples (7 p~g) from lines A, P, Q, and R were electrophoresed through 1% agarose and blotted onto a nylon membrane. The blot was probed with a radiolabeled 1.0-kb Vs1 genomic PstI fragment (22) . Mice A584, P13, Q29, and R18 are analyzed. ern blot data are therefore highly consistent with those of PCR.
The quantitative differences among EsmMyb lines could result from differences in the properties of transgene integration sites, differences in transgene copy number, or both. Importantly, the range of phenotypes displayed by the EsmMyb-transgenic lines is very similar to the range of phenotypes displayed by lines of transgenic mice carrying distinct integrations of an enhancerless (E-) minilocus (22) . We conclude that the EsmMyb minilocus is functionally equivalent to an E-minilocus, and that disruption of the 8E3 Myb-binding site essentially eliminates the ability of E8 to activate VDJ recombination.
Discussion
c-Myb clearly has pleiotropic effects on cell proliferation and differentiation within multiple hematopoietic lineages. It has therefore been difficult to obtain information from either gene-targeting or dominant negative approaches that would implicate c-Myb in the regulation of specific molecular events. As an alternative, we chose to disrupt a functional Myb-binding site within a phenotypically neutral VDJ recombination reporter construct in transgenic mice. This approach has the clear advantage over the gene-targeting and dominant-negative approaches in that any defect in VDJ recombination must be a direct effect of the mutation, rather than an indirect effect that is secondary to a developmental perturbation. Using this strategy, we found that efficient VDJ recombination of a TCR-8 gene reporter construct requires an intact Myb-binding site within the 8E3 element of E 8.
Our data argue strongly that a member of the Myb family plays a crucial role in activating TCR-8 gene rearrangement. However, the disruption of a cis-acting element cannot by itself formally implicate c-Myb. Nevertheless, we have previously shown that c-Myb can bind to the 8E3 site in vitro and can transactivate gene expression in vivo (7) . Furthermore, the activation of TCR-8 gene rearrangement correlates closely with the apparent onset of c-Myb expression in developing hematopoietic cells, c-Myb is known to be expressed at highest levels in immature thymocytes (28) , and the defect in hematopoiesis in c-Myb knockout mice is first apparent at day 14.5 of fetal development (3). In accord with this, VDJ recombination at the endogenous murine TCR-8 locus occurs in the immature CD3-CD4-CD8-population of postnatal thymocytes and is initiated at day 14.5 of fetal development (29, 30) , and the enhancerdependent VD-to-J step of transgenic minilocus rearrangement is activated in the same population of postnatal thymocytes and at the same stage of fetal thymocyte development (23) . Given all of the available data, we conclude that c-Myb plays a direct role in the developmental activation of VDJ recombination at the TCR-8 locus.
It is generally accepted that enhancers regulate VDJ recombination by modulating the accessibility of chromosomal substrates to the recombinase (12) . However, the mechanism by which accessibility is regulated is poorly understood. Although VDJ recombination correlates with germline transcription (14-18), a causal relationship has not been established (24, 31, 32) . Our results implicate a transcription factor that is known to be important for TCR-8 gene transcription as an important regulator of VDJ recombination. Although consistent with the correlation between transcription and rearrangement, our results do not necessarily argue that transcription is causal in activating VDJ recombination. Enhancers can affect local chromatin accessibility, even in the absence of detectable transcription (33, 34) . Thus, the binding ofc-Myb to EB could play a direct role in modulating TCR-8 locus accessibility to the recombinase that is at least in part distinct from its role in transcription. Additional studies are clearly necessary to resolve this issue.
